Pathway Therapeutics' Series A - IV Round

Pathway Therapeutics raised a round of funding on August 19, 2010.

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory dise…

Articles about Pathway Therapeutics' Series A - IV Round: